Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches
Abstract
Soft tissue sarcomas are a rare and heterogeneous disease. For localized disease, treatment is based on surgery and radiotherapy with or without chemotherapy depending on risk factors. Upfront metastases are present in 7 to 20% of cases, and are localized to the lungs in most of cases. Disseminated disease is generally considered incurable but in selected cases, aggressive local treatment of metastases allowed long survival. Treatment of primary tumour is often debated. Our purpose is to evaluate the literature concerning the role of radiotherapy in the management of primary metastatic soft tissue sarcomas.
Source and rights
Published by Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2024. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2024
- Applies to
- 🇫🇷 France
- Scope
- National
- Journal
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
- PubMed
- 38212215











